|
|
Volumn 36, Issue 7, 2001, Pages 773-785
|
|
Current FDA-related drug information: New drugs approved by the FDA. New dosage forms and indications. Agents pending FDA approval
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACCUNEB;
ALEMTUZUMAB;
ALMOTRIPTAN;
ARESTIN;
AVIANE;
AZELAIC ACID;
BIMATOPROST;
CAPECITABINE;
CLEMASTINE FUMARATE;
DROSPIRENONE PLUS ETHINYLESTRADIOL;
ESOMEPRAZOLE;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
FINEVIN;
FORMOTEROL FUMARATE;
HEPATITIS A HEPATITIS B VACCINE;
LANSOPRAZOLE;
LATANOPROST;
LATANOPROST PLUS TIMOLOL MALEATE;
LEVOTHYROXINE SODIUM;
METHYLPHENIDATE;
METHYLPHENIDATE EXTENDED RELEASE;
MINOCYCLINE;
MOXIFLOXACIN;
OLANZAPINE;
PANTOPRAZOLE;
PAROXETINE;
RECOMBINANT ALPHA2B INTERFERON;
RITUXIMAB;
SABELUZOLE;
SALBUTAMOL;
TEGASEROD;
TRAVOPROST;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VALGANCICLOVIR;
VENLAFAXINE;
YASMIN 28;
ZIPRASIDONE;
ACCURACY;
ARTICLE;
DRUG APPROVAL;
DRUG DOSAGE FORM;
DRUG INFORMATION;
FOOD AND DRUG ADMINISTRATION;
INFORMATION;
INTERNET;
PUBLICATION;
|
|
EID: 0034947421
PISSN: 00185787
EISSN: None
Source Type: Journal
DOI: 10.1177/001857870103600712 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
